PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men

By Joensen Ulla Nordström   Veyrand Bruno   Antignac Jean-Philippe   Blomberg Jensen Martin   Petersen Jørgen Holm   Marchand Philippe   Skakkebæk Niels Erik   Andersson Anna-Maria   Le Bizec Bruno   Jørgensen Niels  

Human Reproduction, Vol. 28, Iss. 3, 2013-03 ,pp. : 599-608

Oxford University Press

Access to resources Recommend Favorite

Physiologic Testosterone Therapy has no Effect on Serum Levels of Tumour Necrosis Factor- in Men with Chronic Heart Failure

By Pugh Peter   Jones Richard   Malkin Chris   Hall Joanne   Nettleship Joanne   Kerry Katherine   Hugh Jones T.   Channer Kevin  

Endocrine Research, Vol. 31, Iss. 4, 2005-10 ,pp. : 271-283

Informa Healthcare

Access to resources Recommend Favorite

No effects of n−3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial

By Giltay E. J.   Geleijnse J. M.   Heijboer A. C.   de Goede J.   Oude Griep L. M.   Blankenstein M. A.   Kromhout D.  

International Journal of Andrology, Vol. 35, Iss. 5, 2012-10 ,pp. : 680-687

Blackwell Publishing

Access to resources Recommend Favorite

Association of Serum Adipocytokines with Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C

By  

Digestion, Vol. 83, Iss. 1-2, 2010-09 ,pp. : 32-40

Karger

Access to resources Recommend Favorite

The androgen receptor CAG repeat polymorphism as a risk factor of low serum testosterone and its cardiometabolic effects in men

By Haring R.   Ernst F.   Schurmann C.   Homuth G.   Völker U.   Völzke H.   Nauck M.   Wallaschofski H.  

International Journal of Andrology, Vol. 35, Iss. 4, 2012-08 ,pp. : 511-520

Blackwell Publishing

Access to resources Recommend Favorite